Director – Early Biology
Posted on 7/19/2023
INACTIVE
Relay Therapeutics

201-500 employees

Develops precision medicines using protein motion insights
Company Overview
Relay Therapeutics stands out in the field of precision medicine due to its unique approach of integrating computational power with experimental methods across various scientific fields, enabling a more targeted drug discovery process. The company's culture fosters intellectual stimulation, collaboration, and creativity, attracting a team that is both bright and bold. With a clear focus on patient impact, Relay Therapeutics is committed to developing novel therapies that can potentially transform lives.
AI & Machine Learning
Data & Analytics

Company Stage

IPO

Total Funding

$1.2B

Founded

2016

Headquarters

Cambridge, Massachusetts

Growth & Insights
Headcount

6 month growth

2%

1 year growth

9%

2 year growth

48%
Locations
Cambridge, MA, USA
Experience Level
Entry
Junior
Mid
Senior
Expert
CategoriesNew
Biology & Biotech
Requirements
  • You have earned your Ph.D. and have post-doctoral training in genetics/cell/molecular biology or related field
  • You have proven track record of excellence as evidenced by high impact, peer reviewed publications
  • You have at least 8+ years of experience in biotech/pharma
  • You have experience with cell line profiling, pathway signaling, understanding of genomic drivers, assay development, and compound profiling
  • You can thrive in a dynamic environment, are detail oriented, and are a problem-solver; a strong work ethic and high-level motivation are required
  • You are a great communicator, able to share the impact of efforts and motivate others do great science
  • You are eager to deepen your (and our) understanding of targets and the small molecule drug discovery process
Responsibilities
  • Serve as the Biology lead on teams passionate about developing small molecule modulators of clinically validated targets
  • Help Identify the best targets to expand our portfolio and design biology experiments to assess target dependency and function
  • Develop and validate cell-based models, evaluate candidate small molecules, and support our drug discovery efforts
  • Direct and indirect leadership of individuals and managing external CROs to drive our projects